Co-existence of P(2Y)- and PPADS-insensitive P(2U)-purinoceptors in endothelial cells from adrenal medulla

British Journal of Pharmacology

Volumn 119, Issue 6, 1996, Pages 1223-1232

  Mateo, Jesús ^a   Miras Portugal, Maria Teresa ^a   Castro, Enrique ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Adrenomedullary endothelial cells; Arachidonic acid release; Cytosolic calcium; Fura 2; Purinoceptors; Pyridoxalphosphate 6 azophenyl 2',4' disulphonic acid (PPADS); Suramin

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; ARACHIDONIC ACID; CALCIMYCIN; CALCIUM ION; FURA 2; PURINE P2 RECEPTOR; PURINE P2Y RECEPTOR; PURINE P2Y2 RECEPTOR; PYRIDOXALPHOSPHATE 6 AZOPHENYL 2',4' DISULPHONIC ACID; RECEPTOR SUBTYPE; SURAMIN; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE; CALCIUM; DRUG DERIVATIVE; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; PYRIDOXAL PHOSPHATE-6-AZOPHENYL-2',4'-DISULFONIC ACID;

ADRENAL MEDULLA; ANIMAL CELL; AORTA; ARTICLE; CATTLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR CALCIUM; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; CHEMISTRY; CLASSIFICATION; DRUG EFFECT; METABOLISM; VASCULAR ENDOTHELIUM;

ADENOSINE TRIPHOSPHATE; ADRENAL MEDULLA; ANIMALS; ARACHIDONIC ACID; CALCIUM; CATTLE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; PYRIDOXAL PHOSPHATE; RECEPTORS, PURINERGIC P2; SURAMIN;

EID: 0029658433     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16026.x     Document Type: Article

References (64)

1. 2Y purinoceptors. Pharmacol. Ther., 64, 445-475.
2. ALLSUP, D.J. & BOARDER, M.R. (1990). Comparison of P2 purinergic receptors of aortic endothelial cells with those of adrenal medulla: evidence for heterogenity of receptor subtype and inositol phosphate response. Mol. Pharmacol., 38, 84-91.
3. 2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder. Br. J. Pharmacol., 112, 219-225.
4. BANERJEE, D.K., ORNBERG, R.L. & YOUDIM, M.B.H.E.A. (1985). Endothelial cells from bovine adrenal medulla develop capillary-like growth patterns in culture. Proc. Natl. Acad. Sci. U.S.A., 82, 4702-4706.
5. BARNARD, E.A. BURNSTOCK, G. & WEBB, T.E. (1994). G protein-coupled receptors for ATP and other nucleotides: a new receptor family. Trends. Pharmacol. Sci., 15, 67-70.
6. 2Y. Trends Pharmacol. Sci., 15, 280-281.
7. BOARDER, M.R., WEISMAN, G.A., TURNER, J.T. & WILKINSON, G.F. (1995). G protein-coupled P2 purinoceptors: from molecular biology to functional responses. Trends Pharmacol. Sci., 16, 133-139.
8. BOEYNAEMS, J.M. & PEARSON, J.D. (1990). P2 purinoceptors on vascular endothelial cells: physiological significance and transduction mechanisms. Trends Pharmacol. Sci., 11, 34-37.
9. 2U-purinoceptors. Br. J. Pharmacol., 116, 2413-2416.
10. BRUNER, G & MURPHY, S. (1993). UTP activates multiple second messenger systems in cultured rat astrocytes. Neurosci. Lett., 162, 105-108.
11. BURNSTOCK, G. & KENNEDY, C. (1985). Is there a basis for distinguishing two types of P2 purinoceptor? Gen. Pharmacol., 16, 433-440.
12. CARDINALI, M., SARTOR, O. & ROBBINS, K.C. (1992). Suramin, an experimental chemotherapeutic drug, activates the receptor for epidermal growth factor and promotes growth of certain malignant cells. J. Clin. Invest., 89, 1242-1247.
13. 2+ release from internal stores in adrenal chromaffin cells. Differential sensitivity to UTP and suramin. J. Biol. Chem., 270, 5098-5106.
14. 2-Purinoceptors. Abstract II-18. Atlanta, Georgia.
15. 2+ release in bovine adrenal chromaffin and endothelial cells. Pflügers Arch., 426, 524-533.
16. CHANG, K., HANAOKA, K., KUMADA, M. & TAKUWA, Y. (1995). Molecular cloning and functional analysis of a novel P2 nucleotide receptor. J. Biol. Chem., 270, 26152-26158.
17. COMMUNI, D., PIROTTON, S., PARMENTIER, M. & BOEYNAEMS, J.M. (1995a). Cloning and functional expression of a human uridine nucleotide receptor. J. Biol. Chem., 270, 30849-30852.
18. COMMUNI, D., RASPE, E., PIROTTON, S. & BOEYNAEMS, J.M. (1995b). Coexpression of P2Y and P2U receptors on aortic endothelial cells. Comparison of cell localization and signaling pathways. Circ. Res., 2, 191-198.
19. CONNOLLY, G.P. (1995). Differentiation by pyridoxal 5-phosphate, PPADS and IsoPPADS between responses mediated by UTP and those evoked by alpha, beta-methylene-ATP on rat sympathetic ganglia. Br. J. Pharmacol., 114, 727-731.
20. COUPLAND, R.E. & SELBY, J.E. (1976). The blood supply of the mammalian adrenal medulla: a comparative study. J. Anat., 122, 539-551.
21. FORSBERG, E.J., FEUERSTEIN, G., SHOHAMI, E. & POLLARD, H.B. (1987). Adenosine triphosphate stimulates inositol phospholipid metabolism and prostacyclin formation in adrenal medullary endothelial cells by means of P2-purinergic receptors. Proc. Natl. Acad. Sci. U.S.A., 84, 5630-5634.
22. 2+ mobilization in brain capillary endothelial cells. J. Biol. Chem., 268, 8787-8792.
23. i elevation in rat osteoblastic cells: selective effects on P2Y and P2U signaling pathways. J. Cell. Physiol., 162, 305-314.
24. GHOSH, J. & MILLER, R.A. (1993). Suramin, an experimental chemotherapeutic drug, irreversibly blocks T cell CD45-protein tyrosine phosphatase in vitro. Biochem. Biophys. Res. Commun., 194, 36-44.
25. 2+ homeostasis and formation of cGMP and prostacyclin. Am. J. Physiol., 265, C1620-C1629.
26. 2+ regulation and endothelial vascular function. Endothelium, 1, 223-236.
27. GRYNKIEWICZ, G., POENIE, M. & TSIEN, R.Y. (1985). A new generation of calcium indicators with greatly improved fluorescence properties. J. Biol. Chem., 240, 3440-3450.
28. HALLAM, T.J. & PEARSON, J.D. (1986). Exogenous ATP raises cytoplasmic free calcium in fura-2 loaded piglet aortic endothelial cells. FEBS Lett., 207, 95-99.
29. JORDAN, D.A., BRESLOW, M.J., KUBOS, K.L. & TRAYSTMAN, R.J. (1989). Adrenergic receptors of adrenal medullary vasculature. Am. J. Physiol., 256, H233-H239.
30. KAO, J.P.Y., HAROOTUNIAN, A.T. & TSIEN, R.Y. (1989). Photochemically generated cytosolic calcium pulses and their detection by Fluo-3. J. Biol. Chem., 264, 8179-8184.
31. KELM, M., FEELISCH, M., SPAHR, R., PIPER, H.M., NOACK, E. & SCHRADER, J. (1988). Quantitative and quinetic characterization of nitric oxide and EDRF released from cultured endothelial cells. Biochem. Biophys. Res. Commun., 154, 236-243.
32. KEPPENS S. (1993). The complex interaction of ATP and UTP with isolated hepatocytes. How many receptors? Gen. Pharmacol., 24, 283-289.
33. KIM, H.K., KIM, J.W., ZILBERNSTEIN, A., MERGOLIS, B., KIM, J.G., SCHLESSINGER, J. & RHEE, S.G. (1991). PDGF stimulation of inositol phospholipid hydrolysis requires PLC-gamma I phosphorylation on tyrosine residues 783 and 1254. Cell, 65, 435-441.
34. 2U receptors that increase cytosolic calcium by a phospholipase C- dependent mechanism. J. Neurochem., 66, 604-612.
35. KOPP, R. & PFEIFFER, A. (1990). Suramin alters phosphoinositide synthesis and inhibits growth factor receptor binding in HT-29 cells. Cancer. Res., 50, 6490-6496.
36. LAZAROWSKI, E.R. & HARDEN, T.K. (1994). Identification of a uridine nucleotide-selective G-protein-linked receptor that activates phospholipase C. J. Biol. Chem., 269, 11830-11836.
37. 2U-purinoceptor: potent activation by diadenosine tetraphosphate. Br. J. Pharmacol., 116, 1619-1627.
38. LUSTIG, K.D., SHIAU, A.K., BRAKE, A.J. & JULIUS, D. (1993). Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc. Natl. Acad. Sci. U.S.A., 90, 5113-5117.
39. MANNIX, R.J., MOATTER, T., KELLEY, K.A. & GERRITSEN, M.E. (1993). Cellular signaling responses mediated by a novel nucleotide receptor in rabbit microvessel endothelium. Am. J. Physiol., 265, H675-H680.
40. MIDDAUGH, C.R., MACH, H., BURKE, C.J., VOLKIN, D.B., DABORA, J.M., TSAI, P.K., BRUNER, M.W., RYAN, J.A. & MARFIA, K.E. (1992). Nature of the interaction of growth factors with suramin. Biochemistry, 31, 9016-9024.
41. MIRAS-PORTUGAL, M.T., ROTLLAN, P. & AUNIS, D. (1985). Incorporation of adenosine into nucleotides of chromaffin cells maintained in primary cultures. Neurochem. Int., 7, 89-93.
42. 2U receptors in inositol phosphate response. Circ. Res., 72, 504-510.
43. NEWBY, A.C. & HENDERSON, A.H. (1990). Stimulus-secretion coupling in vascular endothelial cells. Ann. Rev. Physiol., 52, 661-674.
44. O'CONNOR, S.E. (1992). Recent developments in the classification and functional significance of receptors for ATP and UTP, evidence for nucleotide receptors. Life Sci., 50, 1657-1664.
45. PARR, C.E., SULLIVAN, D.M., PARADISO, A.M., LAZAROWSKI, E.R., BURCH, L.H., OLSEN, J.C., ERB, L., WEISMAN, G.A., BOUCHER, R.C. & TURNER, J.T. (1994). Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc. Natl. Acad. Sci. U.S.A., 91, 3275-3279.
46. 5A- from perfused bovine adrenal medulla and isolated chromaffin cells. Life Sci., 48, 2317-2324.
47. PIROTTON, S., RASPE, E. & DEMOLLE, D.E.A. (1987). Involvement of inositol 1,4,5-trisphosphate and calcium in the action of adenine nucleotides on aortic endothelial cells. J. Biol. Chem., 262, 17461-17466.
48. PURKISS, J.R., WILKINSON, G.F. & BOARDER, M.R. (1993). Evidence for a nucleotide receptor on adrenal medullary endothelial cells linked to phospholipase C and phospholipase D. Br. J. Pharmacol., 108, 1031-1037.
49. 2+ - and nitric oxide-dependent stimulation of cyclic GMP synthesis in neuronal cell line induced by P2-purinergic/pyrimidinergic receptor. J. Neurochem., 64, 61-68.
50. RICE, W.R., BURTON, F.M. & FIEDELEY, D.T. (1995). Cloning and expression of the alveolar type II cell P2U-purinergic receptor. Am. J. Respir. Cell. Mol. Biol., 12, 27-32.
51. 5A in bovine adrenal medulla: presence in chromaffin granules. J. Neurochem., 51, 1696-1703.
52. RODRIGUEZ-PASCUAL, F., MIRAS-PORTUGAL, M.T. & TORRES, M. (1996). Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase. Mol. Pharmacol., 49, 1058-1070.
53. ROJAS, E., POLLARD, H.B. & HELDMAN, E. (1985). Real-time measurements of acetylcholine-induced release of ATP from bovine medullary chromaffin cells. FEBS Lett., 185, 323-327.
54. ROSENBLUM, W.I. (1992). Endothelium-derived relaxing factor in brain blood vessels is not nitric oxide. Stroke, 23, 1527-1532.
55. SAMUELSSON, B., DAHLEN, S.E., LINDGREN, J.A., ROUZER, C.A. & SERHAN, C.N. (1987). Leukotrienes and lipoxins: structures, biosynthesis and biological effects. Science, 237, 1171-1176.
56. SEIFERT, R. & SCHULTZ, G. (1989). Involvement of pyrimidinoceptors in the regulation of cell functions by uridine and by uracil nucleotides. Trends Pharmacoi. Sci., 10, 365-369.
57. STEIN, C.A. (1993). Suramin: a novel antineoplastic agent with multiple potential mechanisms of action. Cancer Res., 53, 2239-2248.
58. SUPRENANT, A., BUELL, G. & NORTH, R.A. (1995). P2X receptors bring new structure to ligand-gated ion channels. Trends Neurosci., 18, 224-229.
59. TAKEUCHI, A., KIMURA, T. & SATOH, S. (1992). Enhancement by endothelin-1 of the release of catecholamines from the canine adrenal gland in response to splanchnic nerve stimulation. Clin. Exp. Pharmacol. Physiol., 19, 663-666.
60. TORRES, M., CEBALLOS, G. & RUBIO, R. (1994). Possible role of nitric oxide in catecholamine secretion by chromaffin cells in the presence and absence of cultured endothelial cells. J. Neurochem., 63, 988-996.
61. WHATLEY, R.E., ZIMMERMAN, G.A., MCINTYRE, T.M. & PRESCOTT, S.M. (1990). Lipid metabolism and signal transduction in endothelial cells. Prog. Lipid. Res., 29, 45-63.
62. 2Y-purinoceptors and nucleotide receptors linked to phospholipase C. Br. J. Pharmacol., 108, 689-693.
63. YANAGISAWA, M., KURIHARA, H., KIMURA, S., TOMOBOE, Y., KABAYASHI, MITSUI, Y., GOTO, H. & MASAKI, T. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332, 411-415.
64. ZIGANSHIN, A.U., ZIGANSHINA, L.E., BODIN, P., BAILEY, D. & BURNSTOCK, G. (1995). Effects of P2-purinoceptor antagonists on ecto-nucleotidase activity of guinea-pig vas deferens cultured smooth muscle cells. Biochem. Mol. Biol. Int., 36, 863-869.